Clinical Trial

Shared Decision Making for Antipsychotic Medications

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to provide an evidence-based shared decision making intervention for antipsychotic medications, the Antipsychotic Medication Decision Aid (APM-DA), for individuals experiencing early psychosis and provide, for the first time, an understanding of the shared decision making mechanism of action.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-06-08; most recent amendment 2026-03-24.
Trial Details
NCT Number NCT05416658
Lead Sponsor New York State Psychiatric Institute
Collaborators: Temple University
Conditions Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders, Delusional Disorder, Other Specified Schizophrenia Spectrum and Other Psychotic Disorder
Enrollment 120 participants
Start Date 2027-01-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-30